Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 154127-42-1 | MDL No. : | MFCD09033313 |
Formula : | C10H16N2O6S3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UHIWBQIWXWWDKT-MRVPVSSYSA-N |
M.W : | 356.44 | Pubchem ID : | 15225314 |
Synonyms : |
|
Num. heavy atoms : | 21 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.6 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 8.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 79.55 |
TPSA : | 172.0 Ų |
GI absorption : | Low |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -9.11 cm/s |
Log Po/w (iLOGP) : | 0.61 |
Log Po/w (XLOGP3) : | -0.89 |
Log Po/w (WLOGP) : | 0.93 |
Log Po/w (MLOGP) : | -1.93 |
Log Po/w (SILICOS-IT) : | -0.47 |
Consensus Log Po/w : | -0.35 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 1.0 |
Egan : | 1.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.34 |
Solubility : | 16.5 mg/ml ; 0.0462 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.24 |
Solubility : | 2.05 mg/ml ; 0.00576 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.54 |
Solubility : | 10.3 mg/ml ; 0.0289 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 4.12 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65.2% | Stage #1: With (-)-chlorodiisopinocampheylborane In hexane; tert-butyl methyl ether at -40 - -20℃; Inert atmosphere Stage #2: With sodium hydroxide In hexane; tert-butyl methyl ether; water at 25 - 30℃; |
The cyclisation of compound (Vl) may be carried out using a chiral reducing agent such as (+)-diisopinocamphenylborane (DIPCI) in order to obtain the desired isomer of compound (VII) by a stereoselective reduction. Compound (Vl) (21Og, 0.484 moles) was suspended in t-butyl methyl ether (15 vol) and stirred under nitrogen atmosphere. The stirred suspension was cooled to -400C and (+)-diisopinocamphenylborane (DIPCI) (762g (60-65percent in hexane solution), 1.063 moles) was added via a cannula over a period of 30 minutes. A rise in temperature (upto -300C) was observed. The reaction mixture was maintained at -25 to -2O0C for 3.0 to 4.0 h and monitored by TLC [mobile phase ethyl acetate: hexane, 3:7].After completion of the reduction, 1 M aqueous sodium hydroxide solution (20 vol) was added from an addition funnel over a period of 15-20 minutes, The reaction mixture was stirred at 25-30°C overnight and monitored by TLC[Mobile phase Ethyl acetate: hexane, 1 :1] for completion. After completion, the aqueous and organic phases were separated and the aqueous phase was extracted with t-butyl methyl ether (4.0 vol), acidified to pH 1 using 5N hydrochloric acid solution and extracted with ethyl acetate (3 x 6.0 vol). The combined ethyl acetate extracts were washed with saturated brine solution(2 x 2.5 vol), dried over sodium sulphate and filtered. The organic layer was distilled completely (below 500C) under reduced pressure. The crude product obtained was a pale yellow colored syrup.Yield of compound (VIl): 112 g (65.2percent)Alternatively, step (f) may also be carried out using a non-chiral reducing agent such as sodium tetrahydroborane. In this case, subsequent optical resolution steps, i.e. removal of undesired isomer, have to be carried out. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | Stage #1: With sec.-butyllithium In tetrahydrofuran; cyclohexane at -5 - 0℃; for 8.75 h; Inert atmosphere Stage #2: With sulfur dioxide In tetrahydrofuran; cyclohexane at -65 - 20℃; Inert atmosphere Stage #3: With sodium acetate trihydrate; hydroxylamine-O-sulfonic acid In water at 0 - 20℃; |
Method 2 3,4-Dihydro-4(S)-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide (IX) A solution of the compound from step F (58 g, 0.21 moles) in tetrahydrofuran (1000 ml) was cooled to -5 to 0° C. under nitrogen atmosphere. Sec-butyl lithium (464 ml of 1.4 M solution in cyclohexane) was added to the above solution over 45 min while maintaining the temperature at -5 to 0° C. The mixture was stirred for 8 hours at the temperature less than 0° C. and cooled to -65° C. and sulfur dioxide gas was bubbled through reaction mass at -65° C. till the reaction mixture is acidic. The reaction mixture was stirred overnight while warming it to ambient temperature. The reaction mixture was concentrated to dryness on rotary evaporator to get the lithium sulfinate salt, which was further dissolved in cold water (1160 ml) and washed with ethyl acetate (580 ml). Sodium acetate trihydrate (142.8 g, 1.05 moles) was added and the solution was cooled to 0 to 5° C. Hydroxylamine-O-sulfonic acid (101 g, 0.89 mol) was added slowly to reaction mass below 5° C. The reaction mass was stirred at ambient temperature overnight. The reaction mixture was extracted with ethyl acetate (2*1200 ml)) and the combined extracts were washed with sodium carbonate solution, brine and dried over sodium sulfate. Evaporation to dryness gave a viscous oily compound which was further stirred with dichloromethane (250 ml) to get solid. The product was isolated by filtration. The product was further washed with Dichloromethane, dried in air to yield compound of the formula compound IX (45 g, 60percent). |
[ 154127-41-0 ]
2-(3-Methoxypropyl)-4-oxo-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
Similarity: 0.80
[ 160982-16-1 ]
(S)-6-Chloro-4-hydroxy-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine 1,1-dioxide
Similarity: 0.76
[ 1349199-60-5 ]
3-Ethynyl-1-tosylazetidin-3-ol
Similarity: 0.50
[ 154127-41-0 ]
2-(3-Methoxypropyl)-4-oxo-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
Similarity: 0.80
[ 100342-30-1 ]
N-tert-Butyl-2-thiophenesulfonamide
Similarity: 0.62
[ 286932-39-6 ]
N-tert-Butyl 5-bromo-2-thiophenesulfonamide
Similarity: 0.57
[ 155731-14-9 ]
5-Chlorothiophene-2-sulfonic acid tert-butylamide
Similarity: 0.56
[ 203640-27-1 ]
(R)-3-(1H-Indol-3-yl)-2-(5-(p-tolylethynyl)thiophene-2-sulfonamido)propanoic acid
Similarity: 0.52
[ 154127-41-0 ]
2-(3-Methoxypropyl)-4-oxo-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
Similarity: 0.80
[ 160982-16-1 ]
(S)-6-Chloro-4-hydroxy-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine 1,1-dioxide
Similarity: 0.76
[ 100342-30-1 ]
N-tert-Butyl-2-thiophenesulfonamide
Similarity: 0.62
[ 286932-39-6 ]
N-tert-Butyl 5-bromo-2-thiophenesulfonamide
Similarity: 0.57
[ 155731-14-9 ]
5-Chlorothiophene-2-sulfonic acid tert-butylamide
Similarity: 0.56
[ 154127-41-0 ]
2-(3-Methoxypropyl)-4-oxo-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
Similarity: 0.80
[ 160982-16-1 ]
(S)-6-Chloro-4-hydroxy-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine 1,1-dioxide
Similarity: 0.76